DOI: 10.12890/2020_001708
Eribulin and Confusion: A Previously Unknown Drug Side-Effect
Authors
drabubakersheikh@gmail.com
Keywords
Eribulin, encephalopathy, breast cancerAbstract
Eribulin is an antineoplastic agent used in advanced breast cancer refractory to anthracycline and taxane treatment regimens. A wide variety of side effects with unclear mechanisms have been noted, but encephalopathy has not been widely reported. Here we describe the case of a middle-aged woman treated with eribulin for advanced breast cancer who subsequently developed central nervous system drug-induced toxicity but improved promptly with steroid administration.
Published
2020-06-09
Issue
How to Cite
1.
Sheikh AB, Perisetti A, Javed N, Shekhar R. Eribulin and Confusion: A Previously Unknown Drug Side-Effect. EJCRIM [Internet]. 2020 June 9 [cited 2026 Nov. 18];7(9). Available from: https://ojs.wedare.app/ejcrim/article/view/1708